Achuthan Aruljothy, Siddharth Singh, Neeraj Narula, Gordon W. Moran, Sudheer K. Vuyyuru, Malcolm Hogan, Alexa Zayadi, John K. MacDonald, Benedicte Caron, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma & Vipul Jairath. (2023) Systematic review with meta‐analysis: Medical therapies for treatment of ulcerative proctitis. Alimentary Pharmacology & Therapeutics.
Crossref
Theshani A De Silva, Lotus Alphonsus, Christopher Ma, Malcolm Hogan, Rocio Sedano, Neeraj Narula, Silvio Danese, Laurent Peyrin-Biroulet, John K MacDonald, Siddharth Singh & Vipul Jairath. (2023) Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis. Journal of Crohn's and Colitis 17:1, pages 123-136.
Crossref
Tim Raine, Stefanos Bonovas, Johan Burisch, Torsten Kucharzik, Michel Adamina, Vito Annese, Oliver Bachmann, Dominik Bettenworth, Maria Chaparro, Wladyslawa Czuber-Dochan, Piotr Eder, Pierre Ellul, Catarina Fidalgo, Gionata Fiorino, Paolo Gionchetti, Javier P Gisbert, Hannah Gordon, Charlotte Hedin, Stefan Holubar, Marietta Iacucci, Konstantinos Karmiris, Konstantinos Katsanos, Uri Kopylov, Peter L Lakatos, Theodore Lytras, Ivan Lyutakov, Nurulamin Noor, Gianluca Pellino, Daniele Piovani, Edoardo Savarino, Francesco Selvaggi, Bram Verstockt, Antonino Spinelli, Yves Panis & Glen Doherty. (2022) ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment. Journal of Crohn's and Colitis 16:1, pages 2-17.
Crossref
Brigida Barberio, Jonathan P Segal, M Nabil Quraishi, Christopher J Black, Edoardo V Savarino & Alexander C Ford. (2021) Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis. Journal of Crohn's and Colitis 15:7, pages 1184-1196.
Crossref
Robert Battat, Marjolijn Duijvestein, Leonardo Guizzetti, Daksh Choudhary, Brigid S. Boland, Parambir S. Dulai, Claire E. Parker, Tran M. Nguyen, Siddharth Singh, Niels Vande Casteele, Rish K. Pai, Brian G. Feagan, William J. Sandborn & Vipul Jairath. (2019) Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. American Journal of Gastroenterology 114:5, pages 733-745.
Crossref
Colin B. Peirce & Matthew F. Kalady. 2019. Fundamentals of Anorectal Surgery. Fundamentals of Anorectal Surgery
531
554
.
Hilal Ahmad & Vijay L. Kumar. (2018) Pharmacotherapy of ulcerative colitis – current status and emerging trends. Journal of Basic and Clinical Physiology and Pharmacology 29:6, pages 581-592.
Crossref
Margalida Calafat, Triana Lobatón, Míriam Mañosa, Laura Marín, Noemí Caballero, Macarena Larraín, Eduard Cabré & Eugeni Domènech. (2017) Therapeutic requirements in active ulcerative proctitis: A single-centre study. Gastroenterología y Hepatología 40:10, pages 663-668.
Crossref
Margalida Calafat, Triana Lobatón, Míriam Mañosa, Laura Marín, Noemí Caballero, Macarena Larraín, Eduard Cabré & Eugeni Domènech. (2017) Therapeutic requirements in active ulcerative proctitis: A single-centre study. Gastroenterología y Hepatología (English Edition) 40:10, pages 663-668.
Crossref
Vipul Jairath, GY Zou, Claire E Parker, John K MacDonald, Turki AlAmeel, Mohammad Al Beshir, Majid A Almadi, Talal Al-Taweel, Nathan SS Atkinson, Sujata Biswas, Thomas Chapman, Parambir S Dulai, Mark A Glaire, Daniël R Hoekman, Andreas Koutsoumpas, Elizabeth Minas, Mahmoud H Mosli, Mark Samaan, Reena Khanna, Simon Travis, Geert D'Haens, William J Sandborn & Brian G Feagan. (2017) Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis. Cochrane Database of Systematic Reviews 2017:9.
Crossref
Xiaojing Zhao, Changcheng Zhou, Jingjing Ma, Yunjuan Zhu, Min Sun, Peixue Wang, Yi Zhang, Haiqin Ma & Hongjie Zhang. (2017) Efficacy and safety of rectal 5-aminosalicylic acid versus corticosteroids in active distal ulcerative colitis: a systematic review and network meta-analysis. Scientific Reports 7:1.
Crossref
Jan Wehkamp, Martin Götz, Klaus Herrlinger, Wolfgang Steurer & Eduard F. Stange. (2016) Inflammatory Bowel Disease: Crohn’s disease and ulcerative colitis. Deutsches Ärzteblatt international.
Crossref
Russell D. Cohen & Sushila R. Dalal. (2015) Systematic Review. Inflammatory Bowel Diseases 21:7, pages 1719-1736.
Crossref
Xian-rui Wu, Xiu-li Liu, Seymour Katz & Bo Shen. (2015) Pathogenesis, Diagnosis, and Management of Ulcerative Proctitis, Chronic Radiation Proctopathy, and Diversion Proctitis. Inflammatory Bowel Diseases 21:3, pages 703-715.
Crossref
Alexis P. Calloway & David A. Schwartz. 2015. Inflammatory Bowel Disease. Inflammatory Bowel Disease
73
78
.
Mitchell R. K. L. Lie, Shannon L. Kanis, Bettina E. Hansen & C. Janneke van der Woude. (2014) Drug Therapies for Ulcerative Proctitis. Inflammatory Bowel Diseases 20:11, pages 2157-2178.
Crossref
Sushila Dalal & Russell D. Cohen. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
101
110
.
Prashant R. Mudireddy, Wojciech Blonski & Gary R. Lichtenstein. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
69
99
.
M. Watanabe, H. Nishino, Y. Sameshima, A. Ota, S. Nakamura & T. Hibi. (2013) Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation - a placebo-controlled study. Alimentary Pharmacology & Therapeutics 38:3, pages 264-273.
Crossref
Balakrishnan S. Ramakrishna, Govind K. Makharia, Philip Abraham, Uday C. Ghoshal, Venkataraman Jayanthi, Brij Kishore Agarwal, Vineet Ahuja, Deepak K. Bhasin, Shobna J. Bhatia, Gourdas Choudhuri, Sunil Dadhich, Devendra C. Desai, Gopal Krishna Dhali, Bhaba Dev Goswami, Sanjeev K. Issar, Ajay K. Jain, Rakesh Kochhar, Ajay Kumar, Goundappa Loganathan, Sri Prakash Misra, C. Ganesh Pai, Sujoy Pal, Anna Pulimood, Amarender S. Puri, Ganesh N. Ramesh, Gautam Ray, Shivaram P. Singh, Ajit Sood & Manu Tandan. (2012) Indian Society of Gastroenterology consensus on ulcerative colitis. Indian Journal of Gastroenterology 31:6, pages 307-323.
Crossref
Tessa E.H. Römkens, Milou T. Kampschreur, Joost P.H. Drenth, Martijn G.H. van Oijen & Dirk J. de Jong. (2012) High mucosal healing rates in 5-ASA-treated ulcerative colitis patients: Results of a meta-analysis of clinical trials. Inflammatory Bowel Diseases 18:11, pages 2190-2198.
Crossref
Raja Atreya, H. Neumann & M. F. Neurath. (2012) Wann lokal, wann systemisch wann operativ behandeln?. MMW - Fortschritte der Medizin 154:13, pages 76-79.
Crossref
Irene Sonu, Ming Valerie Lin, Wojciech Blonski & Gary R. Lichtenstein. (2010) Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 39:3, pages 559-599.
Crossref
Asher Kornbluth & David B Sachar. (2010) Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee. American Journal of Gastroenterology 105:3, pages 501-523.
Crossref
John K Marshall, Marroon Thabane, A Hillary Steinhart, Jamie R Newman, Anju Anand & E Jan Irvine. (2010) Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews.
Crossref
Sagar Garud, Alphonso Brown, Adam Cheifetz, Emily B. Levitan & Ciaran P. Kelly. (2007) Meta-Analysis of the Placebo Response in Ulcerative Colitis. Digestive Diseases and Sciences 53:4, pages 875-891.
Crossref
Cyrus P. Tamboli. (2007) Current Medical Therapy for Chronic Inflammatory Bowel Diseases. Surgical Clinics of North America 87:3, pages 697-725.
Crossref
Chinyu Su, James D. Lewis, Brittany Goldberg, Colleen Brensinger & Gary R. Lichtenstein. (2007) A Meta-Analysis of the Placebo Rates of Remission and Response in Clinical Trials of Active Ulcerative Colitis. Gastroenterology 132:2, pages 516-526.
Crossref
Alan C Moss, Adam S Cheifetz & Mark A Peppercorn. (2006) Combined oral and topical mesalazine treatment for extensive ulcerative colitis. Nature Clinical Practice Gastroenterology & Hepatology 3:5, pages 290-293.
Crossref
R. BERGMAN & M. PARKES. (2006) Systematic review: the use of mesalazine in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 23:7, pages 841-855.
Crossref
Jong Beom Park & Hyo Jong Kim. (2006) Medical Treatment of Inflammatory Bowel Disease. Journal of the Korean Medical Association 49:12, pages 1164.
Crossref
Fosca De Iorio, Luigi Benini, Naika Tacchella & Italo Vantini. 2006. Inflammatory Bowel Disease and Familial Adenomatous Polyposis. Inflammatory Bowel Disease and Familial Adenomatous Polyposis
229
238
.
Altamash I. Qureshi & Russell D. Cohen. (2005) Mesalamine delivery systems: do they really make much difference?. Advanced Drug Delivery Reviews 57:2, pages 281-302.
Crossref
Roberta Pica, Omero Alessandro Paoluzi, Federico Iacopini, Adriana Marcheggiano, Pietro Crispino, Margherita Rivera, Antonino Bella, Adriana Consolazio & Paolo Paoluzi. (2004) Oral Mesalazine (5-ASA) Treatment May Protect Against Proximal Extension of Mucosal Inflammation in Ulcerative Proctitis. Inflammatory Bowel Diseases 10:6, pages 731-736.
Crossref
Philippe Seksik, Jean-François Contou, Philippe Ducrotté, Jean-Luc Faucheron & Vincent De Parades. (2004) Traitement de la rectocolite ulcéro-hémorragique dans sa forme distale. Gastroentérologie Clinique et Biologique 28:10, pages 964-973.
Crossref
Asher Kornbluth & David B. Sachar. (2004) Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee. The American Journal of Gastroenterology 99:7, pages 1371-1385.
Crossref
P. Paoluzi, G. D'Albasio, A. Pera, G.Bianchi Porro, O.A. Paoluzi, R. Pica, M. Cottone, M. Miglioli, C. Prantera, G. Sturniolo & S. Ardizzone. (2002) Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Digestive and Liver Disease 34:11, pages 787-793.
Crossref
Daniel A. Lombardi, Edward R. Feller & Samir A. Shah. (2002) Medical management of inflammatory bowel disease in the new millennium. Comprehensive Therapy 28:1, pages 39-49.
Crossref
John K Marshall & Jan E Irvine. (2000) Putting Rectal 5-Aminosalicylic Acid in Its Place: The Role in Distal Ulcerative Colitis. American Journal of Gastroenterology 95:7, pages 1628-1636.
Crossref
Russell D Cohen, Douglas M Woseth, Ronald A Thisted & Stephen B Hanauer. (2000) A Meta-Analysis and Overview of The Literature on Treatment Options for Left-Sided Ulcerative Colitis and Ulcerative Proctitis. American Journal of Gastroenterology 95:5, pages 1263-1276.
Crossref
Philippe Marteau & Christian Florent. (2000) Comparative, open, randomized trial of the efficacy and tolerance of slow- release 5-ASA suppositories once daily versus conventional 5-ASA suppositories twice daily in the treatment of active cryptogenic proctitis. The American Journal of Gastroenterology 95:1, pages 166-170.
Crossref
L. Abreu García, J.L. Martínez Porras & M.I. Vera Mendoza. (2000) Tratamiento médico de la colitis ulcerosa. Medicine - Programa de Formación Médica Continuada Acreditado 8:6, pages 288-290.
Crossref
G. Adler & M. Reinshagen. 2000. Klinische Gastroenterologie und Stoffwechsel. Klinische Gastroenterologie und Stoffwechsel
275
314
.
Robert B. Stein & Stephen B. Hanauer. (1999) MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 28:2, pages 297-321.
Crossref
GIONCHETTI, ARDIZZONE, BENVENUTI, BIANCHI PORRO, BIASCO, CESARI, D'ALBASIO, DE FRANCHIS, MONTELEONE, PALLONE, RANZI, TRALLORI, VALPIANI, VECCHI & CAMPIERI. (2001) A new mesalazine gel enema in the treatment of left‐sided ulcerative colitis: a randomized controlled multicentre trial. Alimentary Pharmacology & Therapeutics 13:3, pages 381-388.
Crossref
G d'Albasio, P Paoluzi, M Campieri, Bianchi G Porro, A Pera, C Prantera, G C Sturniolo & M Miglioli. (1998) Maintenance Treatment of Ulcerative Proctitis With Mesalazine Suppositories: A Double-Blind Placebo-Controlled Trial. American Journal of Gastroenterology 93:5, pages 799-803.
Crossref
P. Gionchetti, F. Rizzello, A. Venturi, M. Ferretti, C. Brignola, M. Miglioli & M. Campieri. (1998) Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Diseases of the Colon & Rectum 41:1, pages 93-97.
Crossref
M. H. Otten, G. de Haas & R. van den Ende. (1997) Colonic range of 5-ASA enemas in healthy individuals, with a comparison of their physical and chemical characteristics. An open, single-dose, randomized, cross-over study. Alimentary Pharmacology and Therapeutics 11:4, pages 693-697.
Crossref
J. Brown, S. Haines & I. R. Wilding. (1997) Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy. Alimentary Pharmacology and Therapeutics 11:4, pages 685-691.
Crossref
P. Gionchetti, A. Venturi, F. Rizzello, C. Corbelli, S. Fanti, M. Ferretti, S. Boschi, M. Miglioli & M. Campieri. (1997) Retrograde colonic spread of a new mesalazine rectal enema in patients with distal ulcerative colitis. Alimentary Pharmacology and Therapeutics 11:4, pages 679-684.
Crossref
Samir A. Shah & Mark A. Peppercorn. (2012) A Comparative Review of Topical Therapies for Inflammatory Bowel Disease. Clinical Immunotherapeutics 6:2, pages 117-129.
Crossref
Massimo Campieri. (1996) What Is the Best Initial Treatment and Maintenance Therapy for Distal Ulcerative Colitis?. Inflammatory Bowel Diseases 2:4, pages 306-307.
Crossref
Guido AdlerGuido Adler. 1996. Morbus Crohn - Colitis ulcerosa. Morbus Crohn - Colitis ulcerosa
242
259
.
J. K. MARSHALL & E. J. IRVINE. (2007) Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis. Alimentary Pharmacology & Therapeutics 9:3, pages 293-300.
Crossref
I. R. WILDING, C. J. KENYON, S. CHAUHAN, G. HOOPER, S. MARSHALL, J. S. McCRACKEN, H. J. STAAB & J. ARMBRECHT. (2007) Colonic spreading of a non‐chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis. Alimentary Pharmacology & Therapeutics 9:2, pages 161-166.
Crossref
Alain Bitton & Mark A. Peppercorn. (1995) Medical Therapy of Ulcerative Proctitis and Proctosigmoiditis, Including Refractory Disease. Inflammatory Bowel Diseases 1:3, pages 207-219.
Crossref
A. B. R. Thomson. 1994. Inflammatory Bowel Disease. Inflammatory Bowel Disease
385
423
.
Massimo Campieri, Paolo Paoluzi, Giuseppe D'Albasio, Gabriele Brunetti, Angelo Pera & Luigi Barbara. (1993) Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. Digestive Diseases and Sciences 38:10, pages 1843-1850.
Crossref
M. A. Peppercorn. (1993) A critical evaluation of the therapeutic benefits and side-effects of aminosalicylate analogues in the treatment of inflammatory bowel disease. InflammoPharmacology 2:3, pages 263-276.
Crossref
WARWICK SELBY. (2008) Current management of inflammatory bowel disease. Journal of Gastroenterology and Hepatology 8:1, pages 70-83.
Crossref
Guido AdlerGuido Adler. 1993. Morbus Crohn Colitis ulcerosa. Morbus Crohn Colitis ulcerosa
211
231
.
Philip F. Schofield, N. Y. Haboubi & D. F. MartinPhilip F. Schofield, N. Y. Haboubi & D. F. Martin. 1993. Highlights in Coloproctology. Highlights in Coloproctology
40
57
.
Frank V. Linn & Mark A. Peppercorn. (1992) Drug therapy for inflammatory bowel disease: Part I. The American Journal of Surgery 164:1, pages 85-89.
Crossref